comparemela.com
  1. Home
  2. Live Updates
  3. Liq Immunopathology - Breaking News

Latest Breaking News On - Liq immunopathology - Page 1 : comparemela.com

Mallinckrodt Announces Publication of Two Journal Manuscripts with Clinical and Economic Evidence for Acthar® Gel (Repository Corticotropin Injection)

/PRNewswire/ Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced the publication of two journal manuscripts.

United statesPrnewswire mallinckrodtDerek belzJeffrey kaplanHayesk actharLiq immunopathologyDanielj specialeDrug administrationMyositis associationArthritis foundationRheumatology centerMallinckrodt pharmaceuticalsOutcomes researchCenters for diseaseSclerosis societyGreen room communications

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.